Opaleye Management Inc. 13D and 13G filings for Harrow Health, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-09 4:05 pm Purchase |
2023-12-31 | 13G | Harrow Health, Inc. HROW |
Opaleye Management Inc. | 3,820,000 10.880% |
45,000 (+1.19%) |
Filing |
| 2023-01-20 4:59 pm Purchase |
2022-12-31 | 13G | Harrow Health, Inc. HROW |
Opaleye Management Inc. | 3,775,000 12.820% |
490,000 (+14.92%) |
Filing |
| 2022-01-25 9:43 pm Purchase |
2021-12-31 | 13G | Harrow Health, Inc. HROW |
Opaleye Management Inc. | 3,285,000 12.200% |
219,584 (+7.16%) |
Filing |
| 2021-02-12 5:20 pm Purchase |
2020-12-31 | 13G | Harrow Health, Inc. HROW |
Opaleye Management Inc. | 3,065,416 11.910% |
3,065,416 (New Position) |
Filing |